ortetamine

{{Short description|Stimulant drug of the amphetamine class}}

{{Drugbox

| IUPAC_name = (±)-1-(2-methylphenyl)propan-2-amine

| image = 2-methylamphetamine.svg

| image_class = skin-invert-image

| width =

| image2 = 2-Methylamphetamine molecule ball.png

| alt2 = Ball-and-stick model of the 2-methylamphetamine molecule

| chirality = Racemic mixture

| drug_name = 2-Methylamphetamine

| INN = Ortetamine

| tradename =

| pregnancy_category =

| legal_status =

| legal_DE = NpSG

| legal_UK = Class A

| legal_US = Schedule II (isomer of Methamphetamine)

| routes_of_administration =

| bioavailability =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 5580-32-5

| ATC_prefix = none

| ATC_suffix =

| PubChem = 115808

| ChemSpiderID = 103572

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = VF4N11KKKR

| C = 10

| H = 15

| N = 1

| smiles = NC(C)CC1=C(C)C=CC=C1

| synonyms = Ortetamine,
O-Tolylaminopropane

}}

Ortetamine (INN), also known as 2-methylamphetamine, is a stimulant drug of the amphetamine class. In animal drug discrimination tests it substituted for dextroamphetamine more closely than either 3- or 4-methylamphetamine, although with only around 1/10 the potency of dextroamphetamine itself.{{cite journal | vauthors = Higgs RA, Glennon RA | title = Stimulus properties of ring-methyl amphetamine analogs | journal = Pharmacology, Biochemistry, and Behavior | volume = 37 | issue = 4 | pages = 835–7 | date = December 1990 | pmid = 2093186 | doi = 10.1016/0091-3057(90)90571-x | s2cid = 40060139 }}